Vertex Pharmaceuticals
Mullu Tessema is a Quality Control Senior Specialist at Vertex Pharmaceuticals since November 2024, bringing extensive experience in the biotechnology and pharmaceutical sectors. Prior roles include Principal Associate Scientist at Frontera Therapeutics from November 2021 to December 2024, Senior QC Analyst (Bio-Assay) at Agenus from November 2019 to October 2021, Analyst II QC Biochem/Cell Biology at Takeda/Shire from September 2015 to October 2019, and QC Analyst at Shire HGT from June 2009 to September 2015. Mullu Tessema holds a Bachelor of Biomedical and Clinical Science from Boston University, earned between 2008 and 2011.
This person is not in any teams
Vertex Pharmaceuticals
87 followers
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.